Ticagrelor versus clopidogrel in patients with acute coronary syndromes - Wikidata - awgldk - TriplyDB

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

http://www.wikidata.org/entity/Q29619002

about

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG)The effect of preoperative treatment of P2Y12 receptor antagonists on perioperative bleeding and mortality in patients treated with coronary artery bypass grafting (CABG)Antiplatelet and anticoagulation for patients with prosthetic heart valves Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallel P2Y12-ADP receptor antagonists: Days of future and past Impact of selective platelet inhibition in reducing cardiovascular risk - role of vorapaxar Thrombosis in ST-elevation myocardial infarction: Insights from thrombi retrieved by aspiration thrombectomy State of the art: Oral antiplatelet therapy 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection The metabolic vascular syndrome - guide to an individualized treatment Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implications Type 2 Diabetes and ADP Receptor Blocker Therapy Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials Acute management of unstable angina and non-ST segment elevation myocardial infarction A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary Stents Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs TIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis Blood cells: an historical account of the roles of purinergic signalling Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar The role of platelets in the recruitment of leukocytes during vascular disease The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19 Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistance

P2860

Q22241786-32AB3CA2-C48E-4047-87CC-EE58625F220D Q22242057-E041EC80-3C3A-4DCA-BB28-DF73B5BD41DE Q24186056-D81F31F5-23D9-4027-B623-B529DFCD7B42 Q24187718-FF7317EE-77B9-4335-AB44-1D5B294082BF Q24197708-8D056644-3917-4286-8040-7CD3047CCC5A Q24201287-9BC82236-690F-40FD-A6D3-FEA31EF96A7C Q24202522-7B542301-35D8-4F56-87F9-957DEDA65E47 Q24202999-889BB420-E18F-4AB0-9A58-6FA8E438DF9D Q24203035-616E6752-E54C-4838-B8FA-B64FDEC95E10 Q24235385-CC43B09C-D3B1-47C0-93AE-1AEEBC3BE49A Q24605508-88BC5873-2B08-4C47-88A9-467EAFF5B56B Q24623137-3F9F2942-C70D-4163-A53A-28BA6442EA1C Q24631111-B5E7E793-09B5-44F6-91F3-791925903471 Q26471900-F829F842-1C08-4696-A6DA-07F93A7510AE Q26740181-F8B2D298-D520-4B9D-9C7E-7301E0489BE3 Q26741051-BD83F13A-8C73-4986-A39E-31B597B55141 Q26741058-F95CA1C7-FC4D-4327-B2DB-B36CEF5DE2BF Q26745619-8FCA4C94-3F78-4804-91F8-20C26635A7DE Q26745754-EA8FA410-9761-4F77-B41A-969AF2E4F502 Q26746148-AC73236B-04D6-46E9-982A-C9746D27413C Q26746161-C0D7F6C0-8147-4E08-B8C2-0F40FA1BBD0F Q26750797-77076BC5-AEDE-41B3-9298-A01A1BC942F0 Q26767142-0B10BD27-7BBF-4B3C-8526-116F356C80E3 Q26771106-659BD904-6014-413F-8A55-FE1A59E38B97 Q26772996-40621931-0286-4595-8F7C-64285501C037 Q26775125-00D70338-625C-4E0E-AC37-7A25F8D6AD82 Q26777116-E9161D6B-A68C-4E50-A661-45F7E2E64E58 Q26782970-DF1B3F7E-32CC-4D6A-AA0B-2535FBCC4E82 Q26783157-60F1BEDD-05A3-4B68-A878-989687B016A6 Q26784131-B1BF8179-E782-4155-AEAC-8CEE49EB94FA Q26785723-DEA8543F-79EE-4D7D-B1CE-7CFFEBAA317B Q26795403-1F40D91D-71A7-4F3A-8DA5-A8A546630067 Q26796466-C4F8A0E6-019C-4BE1-8AB7-E8086D1D93B3 Q26798653-25C1049A-4E01-44AA-8F4D-038204EF699F Q26799623-12BF5646-0BE1-4E94-9C2D-15FC4EDBFFC1 Q26801144-2858DC4D-4783-459A-8D3E-1DB907859C8E Q26801407-DD4C1B59-F3F0-4830-AE65-B912A6E25EA5 Q26801867-BC5A7136-659E-46BA-9A63-6326083D0E0D Q26822796-8946C0BC-D8ED-4143-8693-480C1404F6EF Q26824850-996A6472-CB54-40F3-8F2F-C4D54F08986E

P2860

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

http://www.wikidata.org/entity/Q29619002

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@ast

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@en

type

label

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@ast

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@en

prefLabel

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@ast

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@en

P1433

Q29619002-885C19B6-0E56-44F7-BFE1-03E8E1EFE4DE

P1476

Q29619002-B9970157-D0EC-433C-8388-63FFFFEBD299

P2093

Q29619002-1656BD3A-EFEE-432A-ADA1-BA244BE0507C

Q29619002-3439C21B-3E7B-41D3-A208-CD95F00E777D

Q29619002-391D56AC-24DC-44A6-B608-CA9D63D8FC6C

Q29619002-3D4C1C5D-12FE-4D41-9DD9-8EF21D0DBB78

Q29619002-4652785E-4A39-4E31-B15A-3D1526C7DF0D

Q29619002-4ED1857B-EE96-4050-A5D5-34FD3B30DB35

Q29619002-6C252B1D-E458-4A92-A8ED-9FD0C62F6099

Q29619002-85913F36-387D-485D-BF75-1222F9EE262D

Q29619002-8D85BB01-70D5-4E7C-BCB5-79B1D901CBA8

Q29619002-C06F0FE9-EB44-467E-B08B-3C4BC5CDDB67

P304

Q29619002-448A0665-9B10-45A3-A6C0-42B5A484CF76

P31

Q29619002-2B88BE43-C303-4BE9-B7D9-05CA54E70AC7

P3181

Q29619002-458186C4-64E5-4D57-98B8-19364C1E6292

P356

Q29619002-57317D58-05A7-4261-8B31-C292C7A5893E

P407

Q29619002-74DD9D89-6501-4595-B013-743303F110E9

P433

Q29619002-936D598B-8B91-43A6-9C42-F0EEE7BAACC1

P478

Q29619002-9A34DB6B-9E5A-46F9-A05F-48F7306B276D

P577

Q29619002-1E343A1F-4190-4376-8FD0-252533DFB73E

P698

Q29619002-9E8C3C3A-FE5F-4BA2-9A64-6EA6157F121E

P921

Q29619002-7EB2834D-8204-4E48-AE6B-3D7462629098

P3181

P356

P1433

The New England Journal of Medicine

P1476

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

@en

P2093

Becker RC

http://www.w3.org/2001/XMLSchema#string

Budaj A

http://www.w3.org/2001/XMLSchema#string

Cannon CP

http://www.w3.org/2001/XMLSchema#string

Emanuelsson H

http://www.w3.org/2001/XMLSchema#string

Freij A

http://www.w3.org/2001/XMLSchema#string

Harrington RA

http://www.w3.org/2001/XMLSchema#string

Held C

http://www.w3.org/2001/XMLSchema#string

Horrow J

http://www.w3.org/2001/XMLSchema#string

Husted S

http://www.w3.org/2001/XMLSchema#string

James S

http://www.w3.org/2001/XMLSchema#string

P304

1045-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

568655

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0904327

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19717846

http://www.w3.org/2001/XMLSchema#string

P921